Obstructive sleep apnea comorbid with insomnia symptoms and objective short sleep duration is associated with clinical and preclinical cardiometabolic risk factors: Clinical implications.

Slobodanka PejovicAlexandros N VgontzasJulio Fernandez-MendozaHe FanYun LinMaria KaratarakiEdward O Bixler
Published in: Sleep medicine (2024)
It appears that the additive adverse effects of COMISA on cardiometabolic risks are driven by the ISSD phenotype, a finding with potential implications for further phenotyping COMISA.